Curis
CRIS
#10342
Rank
A$26.21 M
Marketcap
A$0.67
Share price
-2.08%
Change (1 day)
-79.12%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -A$50.91 Million

According to Curis's latest financial reports the company's current earnings are A$11.65 Million. In 2024 the company made an earning of -A$59.94 Million, an increase over its 2023 earnings that were of -A$63.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$50.91 Million-15.06%
2024 -A$59.94 Million-5.77%
2023 -A$63.61 Million-13.1%
2022 -A$73.2 Million27.52%
2021 -A$57.4 Million65.09%
2020 -A$34.77 Million-9.1%
2019 -A$38.25 Million-4.73%
2018 -A$40.15 Million-41.95%
2017 -A$69.16 Million-14.37%
2016 -A$80.76 Million3.55%
2015 -A$77.99 Million271.52%
2014 -A$21 Million76.64%
2013 -A$11.89 Million
2011 -A$10.1 Million27.76%
2010 -A$7.9 Million-43.87%
2009 -A$14.08 Million-23.44%
2008 -A$18.39 Million56.66%
2007 -A$11.74 Million-16.71%
2006 -A$14.09 Million-36.92%
2005 -A$22.34 Million156.25%
2004 -A$8.72 Million-37.24%
2003 -A$13.89 Million-93.34%
2002 -A$0.21 Billion86.79%
2001 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.84 B-32,629.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.44 B-29,576.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$86.71 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.40 B-3,181.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion 782.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-A$34.7 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA